Guardant Health
Guardant Health is a precision oncology company that develops and commercializes blood-based (liquid biopsy) tests and data analytics to detect, monitor, and guide treatment of cancer. It serves oncologists, biopharma companies, and health systems through diagnostic tests, companion diagnostics, and real-world data services. The company generates revenue from test volumes, biopharma partnerships, and related services and products in cancer screening and tumor profiling.
- Revenue
- $563.0M
- Employees
- 2,100
- Founded
- 2012
- Headquarters
- Palo Alto, United States of America
What 6 Arbolus experts think of Guardant Health
NPS scores are uniformly high, with five out of six responses scoring 8 or above. Renewal intent is positive overall, with only one respondent unsure and none negative. All customers report long-term use (over 1 year), indicating high stickiness. Key themes include strong user satisfaction, influential roles among promoters, and long-term renewals among top spenders.Overall Customer Sentiment: Positive
Who reviewed Guardant Health
- C-Suite 67% (4)
- Director 33% (2)
Employer names and spend open once the report publishes.
Tell us when the Guardant Health report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
83 Net Promoter Score, from 6 scored reviews- Promoters 5
- Passives 1
- Detractors 0
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 67%Plan to renew, by seniority
- 50% 2 answers
- 100% 1 answer
- 9.5/10 Average score from customers who will renew
- 10/10 Average score from undecided customers
For people who use Guardant Health
Do you use Guardant Health at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 6 customers of Guardant Health have already contributed
Takes a few minutes. Your identity stays anonymous.